Plné znění - 2/2008 Sb. m. s.

Ministerstvo xxxxxxxxxxxx xxxx xxxxxxx, xx xxx 16. listopadu 2007 bylo xxxxxxxxxx xxxxxxxxx UNESCO, xxxxxxxxxxx Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx sportu¹⁾, xxxxxxxx xxxxxxxxx xxxxxx xxxxx Přílohy I - Xxxxxxx xxxxxxxxxx xxxxx x xxxxx dopingu.

Xxxxxxx I xxxxxxxxx x xxxxxxxx x xxxxxxx x článkem 34 xxxx. 3 Úmluvy xxx 1. ledna 2008 a tímto xxxx xxxxxxxxx x xxxxxxxx x xxx Xxxxxx xxxxxxxxx. Dnem xxxxxx Přílohy X x platnost xxxxxxxx xxxxxx Xxxxxxx X Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx ve xxxxxx xx xxxxx pro xxx 2007, vyhlášená xxx č. 59/2007 Xx. m. x.

Xxxxxxxx znění Xxxxxxx X a xxxx xxxxxxx xx xxxxxxx xxxxxx xx xxxxxxxxx xxxxxxxx.

X1. XXXXXXXXXX LÁTKY

Xxxxxxxxxx xxxxx xxxx xxxxxxxx.

1. XXXXXXXXXX XXXXXXXXXX STEROIDY (XXX):

x. Xxxxxxxx * XXX, xxxxxxxxxx:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3,17-xxxx); xxxxxxxxx (19-xxxxxxxxxxxxxxxx); xxxxxxxxxx; xxxxxxxx; xxxxxxx (xxxxxxxx-1,4-xxxx-3,17-xxxx); xxxxxxx (17α-xxxxxxx-17β-xxxxxxxxxxxxxx-4-xxx[2,3-x]xxxxxxxx); dehydrochlormethyltestosteron (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); desoxymethyltestosteron (17α-xxxxx-5α-xxxxxxx-2-xx-17β-xx); xxxxxxxxxxx; xxxxxxxxxxxxx (19-xxx-17α-xxxxx-4-xx-17-xx); xxxxxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); gestrinon; 4-xxxxxxxxxxxxxxxxxx (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); xxxxxxxxxx; xxxxxxxxx; xxxxxxxxxx; mesterolon; metandienon (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); metenolom; xxxxxxxxxxx; xxxxxxxxxx (2α, 17α-xxxxxxx-5α-xxxxxxxxx-3-xx-17β-xx); xxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9-xxxx-3-xx); xxxxxx-1-xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); methylnortestosteron (17β-hydroxy-17α-metylestr-4-en-3-on); xxxxxxxxxxxxxxx (17β-hydroxy-17α-metylestra-4,9,11-trien-3-on); xxxxxxxxxxxxxxxxx; xxxxxxxxx; xxxxxxxxx; 19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx); xxxxxxxxxx; norethandrolon; xxxxxxxxxxxx; oxabolon; xxxxxxxxxx; xxxxxxxxxxx; oxymetolon; prostanozol ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); xxxxxxxxx; stanozolol; xxxxxxxxx; 1-testosteron (17β-hydroxy-5α-androst-1-en-3-on); xxxxxxxxxxxxxxxxxxx (18α-xxxx-xxxxxx-4,9,11-xxxxx-17β-xx-3-xx); xxxxxxxxx x xxxxx látky x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

x. Xxxxxxxxx ** AAS:

Xxxxxxxxxxxxx (xxxxxxx-5-xx-3β,17β-xxxx), androstendion (xxxxxxx-4-xx-3,17-xxxx), xxxxxxxxxxxxxxxxxx, xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, XXXX), xxxxxxxxxxx x následující xxxxxxxxxx x isomery:

5α-xxxxxxxxx-3α,17α-xxxx xxxxxxx-5-xx-3β,17α-xxxx

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (xxxxxxx-4-xx-3β,17β-xxxx)

5α-androstan-3β,17α-diol 5-androstendion (xxxxxxx-5-xx-3,17-xxxx)

5α-androstan-3β,17β-diol epi-dihydrotestosteron

xxxxxxx-4-xx-3α,17α-xxxx 3α-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-5-xx-3β,17α-xxxx 19-xxxxxxxxxxxxxx

androst-5-en-3α,17α-diol 19-noretiocholanolon

xxxxxxx-5-xx-3α,17β-xxxx

X xxxxxxxxx, xxx může xxxx xxxxxxxxxx androgenní xxxxxxxxxx xxxxxxx xxxxxxxxx, xxxx se mít xx xx, že Xxxxxx xxxxxxxx xxxx Xxxxxxxxx látku a xxxx xxxxxx xxxxxxxxx Xxxxxxxxx laboratorní nález, xxxx xx koncentrace Xxxxxxxx látky xxxx xxxxxx xxxxxxxxxx xxxx xxxxxxxxxxx a/nebo xxxx xx jakýkoli xxxx xxxxxxxxx xxxxx xx Xxxxxx Xxxxxxxxx významně xxxxxxxxx od xxxxxxx xxxxxx, xxxxx xx xxxxxxxx vyskytují x xxxx xxx, xx xxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx. Xxxxxx se xxx za to, xx Xxxxxx obsahuje Xxxxxxxxx látku x xxxxxxx xxxxxxx, xxxxx Xxxxxxxxx prokáže, xx xx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx jejích xxxxxxxxxx nebo indikátorů x/xxxx xxxxxxxxx xxxxx xx Xxxxxx Xxxxxxxxx xxxxxxxx xxxxxxxxxxxxx nebo xxxxxxxxxxxx xxxxxx.

Xxxx xx mít xx xx, že Xxxxxx Xxxxxxxxx obsahuje Xxxxxxxxx xxxxx x xxxxxxxxx xxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx xx xxxxx xxxxxxxxx x při xxxxxxxxx xxxxxxxxxxx, pokud xxx xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) prokázat, xx xx Xxxxxxxx xxxxx xxxxxxxxxx původu. X xxxxxxx xxxxxxx xxxx xxxxx xxxxxxxx xxxxx xxxxxxx.

Když se xxxxxxx xxxxxxxx analýzy xxxxxxxx xxxxxxxxxxx od xxxxxxx hodnot, které xx xxxxxxxx vyskytují x xxxx a xxxxx spolehlivá xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx exogenní xxxxx Xxxxxxxx xxxxx, ale xxxxxxxx známky použití Xxxxxxxx látky, xxxx xxxx. porovnání x xxxxxxxxxxx referenčními steroidními xxxxxxx, xxxx xxxx xxxxxxxxx nahlásila xxxxx X/X xxxxx než xxxxx (4) xx xxxxx (1) x xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. IRMS) xxxxxxxxxxx exogenní původ xxxxx, provede xxxxxxxxx Xxxxxxxxxxxxx organizace xxxxx xxxxxxx porovnáním xxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxxxxxxx xxxxxxxxxx xxxxx.

Xx-xx xxxxxxxxxx xxxxxx xxxxx xxxxxxx, xxx xxxxxxxx xxxx xxxxxxxxxx xxxxxx xxxx xxxxxxxxx x xx xxxx xxxxxxxxx. Xxxxx laboratoř xxxxxxx, za použití xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. IRMS) exogenní xxxxx Xxxxxxxx xxxxx, xxxx xxxxx xxxxxxxx xxxxx xxxxxxx, x xxxx xx mít xx to, xx Xxxxxx xxxxxxxx Zakázanou xxxxx. Xxxxx xxxxxx xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) x xxxxxx x xxxxxxxxx xxxxxxxxx 3 xxxxxxxxx testy, xxxx xxxxxxx xxxxxxxxxxxxxx xxxxxx Xxxxxxxxx xxx, že xxxx příslušnou Antidopingovou xxxxxxxxxx x následujících 3 xxxxxxxx xxxxxxx xxxxxxxx xxx xxxxxxxxxxx xxxxxxxx. Xxxxxxxx, xxxxx xxxxxxxxxx xxxx longitudinální xxxxxx, xxxx xxxxxx xxxx xxxxxxxxx. Xxxxx xxxxxxxxxxxxxx xxxxxx Xxxxxxxxx, xxxxxxxx xxxxxxxxxx xxxxx, xxxx xxxxxxxxxxxx xxxxxxxx, xxxx xx pak xxxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx xxxxx.

X xxxxxxxx vzácných individuálních xxxxxxxxx může xxx x moči trvale xxxxxxx boldenon xxxxxxxxxxx xxxxxx ve xxxxxx xxxxxx xxxxxxxxxxxxx (ng/ml). Xxxxx laboratoř xxxxxx xxxxx xxxxxxxxx a xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx látky, xxxx xxx provedeno xxxxx xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxx (xxxxxxxxxx xxxxx).

Xxxxx laboratoř xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx 19-xxxxxxxxxxxxxxx, xxxx se xx xxxxxxxxx za xxxxxxx x xxxxxxxxxxx xxxxx xxxxxxxxxx xxxxxx Xxxxxxxx xxxxx. X xxxxxxx xxxxxxx xxxx xxxxx xxxxxxxx xxxxx xxxxxxx.

X xxxxxxx, xx Sportovec xxxxxx xxxxxxxxxxxxx xxx xxxxxxx xxxxxxxxx, xxxx se xxx xx xx, xx Xxxxxx Xxxxxxxxx xxxxxxxx Xxxxxxxxx xxxxx.

2. Ostatní anabolické xxxxx, xxxxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxx xxxxxxxxxx androgenových xxxxxxxxx (XXXX), xxxxxxx, xxxxxxx, xxxxxxxxxx, ale xx x omezením xxxxx xx xx.

X2. XXXXXXX X PŘÍBUZNÉ XXXXX

Xxxxxxxxxxx látky x jejich uvolňující xxxxxxx jsou zakázány:

1. Xxxxxxxxxxxx (XXX);

2. Růstový hormon (xXX), insulinu xxxxxxx xxxxxxx xxxxxxx (např. XXX-1), xxxxxxxxxx růstové xxxxxxx (XXX);

3. Xxxxxxxxxxxxx (např. XX, xXX), zakázané jen x xxxx;

4. Xxxxxxxx;

5. Xxxxxxxxxxxxxx

x další látky x podobnou xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxx Xxxxxxxxx nemůže prokázat, xx xxxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxxx xx xxxxxxxxxxxx xxxxxx, bude xx xxx za xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx (xxx xx xxxxxxx xxxx) x xxxxxxxxx, xxx koncentrace Zakázané xxxxx xxxx xxxxxx xxxxxxxxxx či xxxxxxxxxx x/xxxx xxxxxxxxx xxxxxx xx Xxxxxx Xxxxxxxxx xxxxxxx překročí xxxxxxx xxxxxxxx xxxxxxxx x xxxx xxx, xx xxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx.

Xxxxx xxxxxxxxx xxxxxxxxx, xx užití xxxxxxxxxx analytické xxxxxx, xx Xxxxxxxx xxxxx xx xxxxxxxxxx xxxxxx, xxxx xx mít xx xx, že Xxxxxx obsahuje Xxxxxxxxx xxxxx x xxxx xxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx.

S3. XXXX-2 XXXXXXXX

Xxxxxxx xxxx-2 agonisté xxxxxx xxxxxx X- a X-xxxxxxx xxxx xxxxxxxx.

Xxxxxxxx jsou formoterol, xxxxxxxxxx, xxxxxxxxxx a xxxxxxxxxx, xxx které xx při xxxxxxxx xxxxx xxxxxxx zkrácené xxxxxxxxxxxx výjimky.

I xxxx xxxx xxxxxxx xxxxxxxx xxxxx xxxxxxxxxxxx xxxxxxx, xxxx xxxxx xxxxxxxxxxx (volný xxxx xxxxxxxxxx) vyšší xxx 1000 nanogramů v 1 mililitru xxxx xxxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx nález, xxxxx Xxxxxxxxx xxxxxxxxx, xx xxxxxxxxxx xxxxxxxx xxx xxxxxxxx terapeutickým užíváním xxxxxxxxxxx x inhalaci.

X4. ANTAGONISTÉ X MODULÁTORY XXXXXXX

Xxxxxxxxxxx xxxxxxx xxxx xxxxxxxx:

1. Xxxxxxxxxx xxxxxxxx, xxxxxxxxxx:

2. Xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (XXXX), xxxxxxxx:

3. Xxxxxxx xxxxxxxxxxxxxx látky xxxxxxxxxx:

4. Xxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxx včetně xxxxxxxxxx xxxxxxxxxx, ale ne x xxxxxxxx xxxxx xx xx.

X5. XXXXXXXXX X XXXXXXX XXXXXXXXX LÁTKY

Xxxxxxxxx xxxxx xxxx xxxxxxxx. Xxxxxxxx:

Xxxxxxxxx*, xxxxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx xxxx-xxxxxxxxx (xxxx. xxxxxxxxxx, xxxxxxxxxx), xxxxxxxxxxxxxxx (xxxx. xxxxxxx, dextran, xxxxxxxxxxxxxxxxx) x xxxxx xxxxx x podobnými xxxxxxxxxxxx xxxxxx.

Diuretika xxxxxxxx:

Xxxxxxxxxxxx, xxxxxxxx, xxxxxxxxx, furosemid, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxx, xxxxxxxx xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx (xxxx. xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxx, chlorothiazid), xxxxxxxxxx x xxxxx xxxxx x podobnou chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx (xxxxx xxxxxxxxxxxx, který není xxxxxxxx).

* Xxxxxxxxxxxx xxxxxxx není xxxxxx, xxxxx moč Xxxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxx x xxxxxxxx xxxx podprahovou hladinou xxxx Xxxxxxxx xxxxx (xxxxx).

X1. XXXXXXXXX XXXXXXX XXXXXXX

Xxxxxxxx xx xxxxxxxxxxx:

X2. XXXXXXXX X FYZIKÁLNÍ MANIPULACE

X3. XXXXXX XXXXXX

Xxxxxxxxxxxxxx xxxxxxx xxxxx, genů, xxxxxxxx xxxxxxxx, nebo xxxxxxxxxx xxxxxxx genů, xxxxx mají schopnost xxxxxx sportovní xxxxx, xx xxxxxxxx.

X6. XXXXXXXXXXX

Xxxxxxx xxxxxxxxxxx (xxxxxx obou xxxxxx xxxxxxxxxx xxxxxxxxx (X- x X-) xxxxxxx) xxxx xxxxxxxx, x xxxxxxxx xxxxxxxx xxxxxxxxx v xxxxxxx xxxxxx místního xxxxx x xxxxxxxxxxx zahrnutých xx Monitorovacího xxxxxxxx xxx rok 2008.

Xxxxxxxxxxx zahrnují:

Xxxxxxxxx, xxxxxxxxx**, amfepramon, xxxxxxxxxxx, xxxxxxxxxx, amfetamin, xxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, efedrin****, xxxxxxxx, xxxxxxxxx, ethylamfetamin, xxxxxxxxxxx, xxxxxxxxxxx, fendimetrazin, fenetylin, xxxxxxxxxxx, fenkamfamin, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, 4-fenylpiracetam (karfedon), xxxxxxxxxx, heptaminol, isomethepten, xxxxx***, xxxxxxxxxxx, xxxxxx, xxxxxxxxxxx, krotetamid, xxxxxxxxxxxxxxx, xxxxxxxxx, mefentermin, xxxxxxxxxxxx, xxxxxxxxxxxx (D-), metylefedrin****, xxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxxxxxxxxx, methylfenidát, xxxxxxxx, xxxxxxxxx, niketamid, xxxxxxxxxxx, norfenfluramin, xxxxxxxxx, xxxxxxxxx, oxilofrin, parahydroxyamfetamin, xxxxxxx, xxxxxxxxxxx, x-xxxxxxxxxxxxxxx, xxxxxxxxx, propylhexedrin, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx x xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx nebo podobnými xxxxxxxxxxxx účinky.

Xxxxxxxxxxxx xxxxxxxxx xxxxxxxx xxxx příklady x xxxxx oddíle xxxx xxxxxxxxxx xx specifickou xxxxx pouze, xxxxx Xxxxxxxxx xxxxxxx, xx xxxx xxxxxxxxx xxxxxxxxxx x xxxxxxx xxxxxxxxx xxxxxxxxxxx umožňuje xxxxxxxxx xxxxxxxx antidopingových pravidel, xxxx xx x xxx menší pravděpodobnost, xx xxxx úspěšně xxxxxxxx jako xxxxxxxxx xxxxx.

X7. XXXXXXXXX

Následující narkotika xxxx zakázaná:

Xxxxxxxxxxx, xxxxxxxxxxxxx, diamorfin(heroin), fentanyl x xxxx xxxxxxxx, xxxxxxxxxxx, xxxxxxx, xxxxxx, xxxxxxxx, oxymorfon, pentazocin, xxxxxxx.

X8. XXXXXXXXXXX

Xxxxxxxxxxx (např. xxxxx, xxxxxxxxx) xxxx xxxxxxxx.

S9. XXXXXXXXXXXXXXXXXXXX

Všechny glukokortikosteroidy xxxxxxxx xxxxxx, xxxxxxxx, xxxxxxxxxx nebo xxxxxxxxxxxxx xxxxxxxx jsou xxxxxxxx. Xxxxxx xxxxx xxxxxxxx xxxxxxxxxxxxx xxxxxxx.

Xxxx xxxxxxx xxxxxxxx aplikace (xxxxxxxxxxxx, xx xxxxx xxxxxx, xx okolí xxxxxx, xxxxxxxxxx, xx xxxx) x xxxxxxxxx xxxxxxxx vyžadují zkrácenou xxxxxxxxxxxxx xxxxxxx s xxxxxxxx níže xxxxxxxxx.

Xxxxxxx přípravky podávané xx xxxxxx xxxxx (xxxxxx xxxxxxxxxxx/xxxxxxxxxx), ušní, xxxxx, xxxx, xxxxxx xxxxx xxxxxxx xxxxxx, xxxxxxxx xxx x xxxxx xxxxxx xxxxxxxx x xxxxxxxxxx xxxxxx xxxxx xxxxxxxxxxxx výjimky.

P1. XXXXXXX

Xxxxxxx (etanol) xx xxxxxxxx xxxxx Xxx xxxxxxx x xxxxxxxxxxxxx xxxxxxxx. Xxxxxxx xx xxxx xxxxxxxx xxxxxxxx xxxxxxxx a/nebo xxxxxxxx xxxx. Xxxxxxx xxxxxxx xxx xxxxxxxx xxxxxxxxxxx xxxxxxxx (xxxxxxxxxxxxx xxxxxxx) je pro xxxxxx federaci xxxxxxx x xxxxxxxxx.

∙ Xxxxxxxxxxxx sport (XXX) (0.10 x/x)

∙ Xxxxxx (XXX) (0.10 x/x)

∙ Letecké xxxxxx a xxxxxxxxxxxx (XXX) (0.20 x/x)

∙ Xxxxxxxxxxx (FITA, XXX) (0.10 g/l)

∙ Xxxxxxx pětiboj (XXXX) xxx xxx xxxxxxxxxx se xxxxxxxx (0.10 x/x)

∙ Xxxxxxxxxxx xxxxx (XXX) (0.10 g/l)

∙ Xxxxx motorismus (XXX) (0.30 x/x)

∙ Kuželky (IPC) (0.10 x/x)

X2. XXXX-XXXXXXXXX

Xxxxx xxxx xxxxx xxxxxx, xxxx-xxxxxxxxx jsou xxxxxxxx xxxxx Při xxxxxxx x xxxxxxxxxxxxx sportech.

∙ Automobilový xxxxx (XXX)

∙ Xxxxxxxx (XXXX)

∙ Xxxx (XXXX)

∙ Bridž (XXX)

∙ Xxxxxxx (XXX)

∙ Xxxxxxxxxx (XXX)

∙ Jachting (XXXX) - "xxxxx xxxx" - xxx xxxxxxxxxxx

∙ Kuželky (XXX)

∙ Xxxxxxx xxxxxx x parašutismus (XXX)

∙ Xxxxxxxxxxx (XXXX, XXX) (zakázané xxxx Xxxx xxxxxx)

∙ Lyžování (FIS) - skoky xx xxxxxx x akrobatické xxxxxxxx-xxxxx x X-xxxxx, x xxxxxxxxx U-rampa x "xxx air"

∙ Xxxxxxx xxxxxxx (XXXX) - xxx xxxxxxxxxx se xxxxxxxx

∙ Xxxxxxxxxxx xxxxx (XXX)

∙ Xxxxxxxx x xxxxxxx xxxxxx (XXXX, XXX "xxxxx")

∙ Xxxxxxx (XXXX, XXX) (xxxxxxxx také Xxxx xxxxxx)

∙ Xxxxx motorismus (XXX)

∙ Zápas (FILA)

Xxxx-xxxxxxxxx xxxxxxxx xxxxxxxxxxx xxxxx:

Xxxxxxxxxx, alprenolol, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx, celiprolol, xxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, metipranolol, metoprolol, xxxxxxx, oxprenolol, xxxxxxxx, xxxxxxxxxxx, xxxxxxx, xxxxxxx, xxx xx x xxxxxxxx xxxxx xx xx

"Xxxxxxxxxx látky"* xxxx xxxxxxxxxxx níže:

∙ Všichni Beta-2 xxxxxxxx x xxxxxxxx, xxxxx xxxxxxxxxxx (xxxxxxx xxxx xxxxxxxxxxx) xxx xxxxxxxx xxxxxx xxx 1000 xx/xx moči x xxxxxxxxxxxx (xxxxxxx xx skupině X 1.2 Xxxxxxx xxxxxxxxxx xxxxx);

∙ Inhibitory xxxx-xxxxxxxxx, xxxxxxxxxx;

∙ Xxxxx, kropropamid, xxxxxxxxxx, xxxxxxx, etamivan, famprofazon, xxxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxxxxx, x-xxxxxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, sibutramin, xxxxxxxxxxxxx a všechna xxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxx x oddíle X6, xxx xxxxx Xxxxxxxxx xxxxxxx, xx xxxxxxx xxxxxxxx popsané x xxxxxx S6;

∙ Kanabinoidy;

∙ Xxxxxxx Xxxxxxxxxxxxxxxxxxxx;

∙ Xxxxxxx;

∙ Všechny Xxxx-xxxxxxxxx.

*"X Seznamu xxxxx xxx xxxxxxxxxxx xxxxxxxxxx xxxxx, xxxxx xxxxxxxx xxxxxxxx neúmyslné xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxxxxx xxxx všeobecně xxxxxxxx x běžných xxxxxxxxx přípravcích, xxxx x xxxxx xx xxxxx xxxxxxxxxxxxxxx, xx xxxxx xxxxxxx xxxxxxxx xxxx dopingová činidla." Xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxxxxxxx takovéto xxxxx xxxx xxxxxxxx xxxxxxx xxxxxx xx xxxxxxxxxxx, xx "...Sportovec xxxx xxxxx prokázat, xx Xxxxxxx xxxxxxxxxx xxxxx xxxxxx zamýšleno xx xxxxxxx xxxxxxxxxxx xxxxxx...".

Xxxxxx předpis x. 2/2008 Sb. x. x. xxxxx xxxxxxxxx xxxx 31.1.2008.

Xxxxxx xxxxxxx x. 2/2008 Xx. x. x. byl zrušen xxxxxxx xxxxxxxxx č. 8/2009 Sb. m. s. x účinností xx 7.2.2009.

Znění xxxxxxxxxxxx právních norem xxxxxx xxxxxxxx xxxxxxxx x odkazech xxxx xxxxxxxxxxxxx, xxxxx se xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.